Search

From hardcore peptide biochemist to translational scientist, it’s been an unconventional journey for Jennifer Van Eyk, Director of the Advanced Clinical Biosystems Research Institute at Cedars-Sinai Medical Center, Los Angeles.

The combination of genomic profiling and high-tech targeted drug delivery is opening up a new front in the fight against cancer.

Whether you are a scientist working on a new intervention or a policy-maker trying to solve major public health problems, social and cultural factors are crucial pieces of the puzzle – ignore them at your peril. Here, I explain how social science can help.

Sitting Down With… Jennifer Grandis, Professor, Department of Otolaryngology – Head and Neck Surgery, Associate Vice Chancellor – Clinical and Translational Research, University of California, San Francisco, USA.

When Ewan McNay was eight years old, he decided that he wanted to do two things: live forever and find out how the brain works.

We need better tools for assessing new medicines – and to develop them, we must work together.

In the pharma industry of the future, only the strongest companies will survive – and that means those with the most successful collaborations.

Autocrine-based screening has identified a more selective anti-diabetic drug candidate

CRISPR has brought gene editing into the mainstream – but where should we draw the line?

Data from a large-scale trial suggest that screening cuts ovarian cancer mortality rates by 25 percent – but some remain skeptical